KANE BIOTECH INC (KNE.CA) Stock Cash Flow
Canada - TSX Venture Exchange - TSX-V:KNE - CA4838092084 - Common Stock
0.03 CAD
-0.01 (-14.29%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.26M | 6.17M | -5.27M | -3.82M | -4.85M | |||
| Depreciation Amortization | 204.60K | 217.30K | 242.10K | 263.40K | 188.00K | |||
| Income Taxes - Deferred | N/A | -1.31M | 0.00 | N/A | N/A | |||
| Change In Working Capital | -110.00K | -320.00K | 1.72M | 394.50K | 1.65M | |||
| Interest Paid | 60.00K | 960.00K | 260.00K | N/A | N/A | |||
| Other non cash items | 2.05M | -8.87M | 1.23M | 122.70K | 722.50K | |||
| OPERATING CASH FLOW | -2.84M | -4.11M | -2.08M | -3.04M | -2.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -140.00K | -90.00K | -50.00K | -87.60K | -353.50K | |||
| Other Investing Activity | 0.00 | 10.00M | 760.00K | -20.00K | -20.00K | |||
| INVESTING CASH FLOW | -90.00K | 10.00M | 710.00K | -107.60K | -373.60K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 430.00K | -6.65M | 1.53M | 2.25M | 1.25M | |||
| Stock Issued/Repurchased | N/A | 500.00K | 420.00K | 973.70K | 1.12M | |||
| Other Financing Activity | 40.00K | -1.53M | 210.00K | -120.60K | 445.30K | |||
| FINANCING CASH FLOW | 3.50M | -7.69M | 2.16M | 3.10M | 2.81M | |||
| CHANGE IN CASH | 570.00K | -1.80M | 790.00K | -48.20K | 145.20K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.84M | -4.11M | -2.08M | -3.04M | -2.29M | |||
| Capital Expenditure | -140.00K | -90.00K | -50.00K | -87.60K | -353.50K | |||
| FREE CASH FLOW | -2.98M | -4.20M | -2.13M | -3.13M | -2.64M | |||
All data in CAD